← Evidence map

Observational studyDrug safety2026

Short-Term and Long-Term Safety Analyses of Brexpiprazole for Agitation Associated with Dementia due to Alzheimer's Disease: Timing and Duration of Adverse Events.

Anton P Porsteinsson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

4 trials

Full record →Abstract, authors, funding and every citing paper · PMID 41961243